299 related articles for article (PubMed ID: 2655479)
1. Rate of activation of renin-angiotensin-aldosterone axis and sodium intake in rats.
Holtzman E; Braley LM; Menachery A; Williams GH; Hollenberg NK
Am J Physiol; 1989 May; 256(5 Pt 2):H1311-5. PubMed ID: 2655479
[TBL] [Abstract][Full Text] [Related]
2. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
McCaa RE
Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II and not sodium status is the major determinant of the agonistic/antagonistic balance of saralasin's actions.
Fagard R; Amery A; Lijnen P
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():75s-78s. PubMed ID: 7004740
[TBL] [Abstract][Full Text] [Related]
4. Adrenal responses to pharmacological interruption of the renin-angiotensin system in sodium-restricted normal man.
Williams GH; Hollenberg NK; Brown C; Mersey JH
J Clin Endocrinol Metab; 1978 Oct; 47(4):725-31. PubMed ID: 400731
[TBL] [Abstract][Full Text] [Related]
5. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
[TBL] [Abstract][Full Text] [Related]
6. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
Carey RM; Vaughan ED; Peach MJ; Ayers CR
J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
[TBL] [Abstract][Full Text] [Related]
7. In vivo effects of angiotensin antagonists on plasma aldosterone in the dog.
Beckerhoff R; Uhlschmid G; Furrer J; Nussberger J; Schmied UR; Vetter WJ; Siegenthaler W
Eur J Pharmacol; 1975 Dec; 34(2):363-7. PubMed ID: 1234555
[TBL] [Abstract][Full Text] [Related]
8. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
9. Sodium space and intravascular volume: dietary sodium effects in cystic fibrosis and healthy adolescent subjects.
Legris GJ; Dearborn D; Stern RC; Geiss CL; Hopfer U; Douglas JG; Doershuk CF
Pediatrics; 1998 Jan; 101(1 Pt 1):48-56. PubMed ID: 9417150
[TBL] [Abstract][Full Text] [Related]
10. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
Agabiti-Rosei E; Brown JJ; Brown WC; Fraser R; Trust PM; Lever AF; Morton JJ; Robertson JI
Clin Endocrinol (Oxf); 1979 Mar; 10(3):227-34. PubMed ID: 455738
[TBL] [Abstract][Full Text] [Related]
11. Role of adrenal renin-angiotensin system in the control of aldosterone secretion in sodium-restricted rats.
Mazzocchi G; Malendowicz LK; Markowska A; Albertin G; Nussdorfer GG
Am J Physiol Endocrinol Metab; 2000 Jun; 278(6):E1027-30. PubMed ID: 10827004
[TBL] [Abstract][Full Text] [Related]
12. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
[TBL] [Abstract][Full Text] [Related]
13. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.
Case DB; Wallace JM; Keim HJ; Sealey JE; Laragh JH
Am J Med; 1976 May; 60(6):825-36. PubMed ID: 1020762
[TBL] [Abstract][Full Text] [Related]
14. Sodium-mediated modulation of aldosterone secretion: impact of converting enzyme inhibition on rat glomerulosa cell response to angiotensin-II.
Braley LM; Menachery A; Rystedt L; Williams GH
Endocrinology; 1989 Sep; 125(3):1310-4. PubMed ID: 2547581
[TBL] [Abstract][Full Text] [Related]
15. Primacy of the renin-angiotensin system in mediating the aldosterone response to sodium restriction.
Swartz SL; Williams GH; Hollenberg NK; Dluhy RG; Moore TJ
J Clin Endocrinol Metab; 1980 Jun; 50(6):1071-4. PubMed ID: 6989849
[TBL] [Abstract][Full Text] [Related]
16. Effect of angiotensin II and of an angiotensin II analogue (Sar1-Ile8-angiotensin II) on blood pressure, plasma aldosterone and plasma renin activity in the dog.
Beckerhoff R; Uhlschmid G; Vetter W; Armbruster H; Nussberger J; Reck G; Schmied U; Siegenthaler W
Clin Sci Mol Med Suppl; 1975 Jun; 2():41s-44s. PubMed ID: 1077788
[TBL] [Abstract][Full Text] [Related]
17. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.
McCaa RE
Prog Biochem Pharmacol; 1980; 17():29-35. PubMed ID: 7010367
[TBL] [Abstract][Full Text] [Related]
18. Interrenal function in larval Ambystoma tigrinum. IV. Acid-base balance and the renin-angiotensin system.
Eskandari S; Stiffler DF
Gen Comp Endocrinol; 1997 Jan; 105(1):18-30. PubMed ID: 9000464
[TBL] [Abstract][Full Text] [Related]
19. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
[TBL] [Abstract][Full Text] [Related]
20. Time course of enhanced adrenal responsiveness to angiotensin on a low salt diet.
Rogacz S; Williams GH; Hollenberg NK
Hypertension; 1990 Apr; 15(4):376-80. PubMed ID: 2318519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
